Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check2 days agoChange DetectedThe page shows an updated site revision from v3.6.0 to v3.6.2, reflecting a platform update behind the page rather than changes to the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record now indicates that recruitment is closed to accrual. Additionally, new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the footer revision note updated to Revision: v3.6.0, with a minor formatting change to the Intervention/Treatment label.SummaryDifference0.4%

- Check23 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5. This signals a minor update to the page's revision history without altering the study details presented.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed. This denotes a newer revision of the study record and acts as metadata rather than content changes.SummaryDifference0.1%

- Check59 days agoChange DetectedThe study page now shows Revision: v3.5.3. This indicates an updated revision of the study documents.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.2 has been added to the page, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.